Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT).

BACKGROUND AND PURPOSE We have developed a linear accelerator synchronized with a fluoroscopic real-time tumor-tracking system to reduce errors due to setup and organ motion. In the real-time tumor-tracking radiation therapy (RTRT) system, the accuracy of tumor tracking depends on the registration of the marker's coordinates. The registration accuracy and possible migration of the internal fiducial gold marker implanted into prostate and liver was investigated. MATERIALS AND METHODS Internal fiducial gold markers were implanted in 14 patients with prostate cancer and four patients with liver tumors. Computed tomography (CT) was carried out as a part of treatment planning in the 18 patients. A total of 72 follow-up CT scans were taken. We calculated the relative relationship between the coordinates of the center of mass (CM) of the organs and those of the marker. The discrepancy in the CM coordinates during a follow-up CT compared to those recorded during the planning CT was used to study possible marker migration. RESULTS The standard deviation (SD) of interobserver variations in the CM coordinates was within 2.0 and 0.4 mm for the organ and the marker, respectively, in seven observers. Assuming that organs do not shrink, grow, or rotate, the maximum SD of migration error in each direction was estimated to be less than 2.5 and 2.0 mm for liver and prostate, respectively. There was no correlation between the marker position and the time after implantation. CONCLUSION The degree of possible migration of the internal fiducial marker was within the limits of accuracy of the CT measurement. Most of the marker movement can be attributed to the measurement uncertainty, which also influences registration in actual treatment planning. Thus, even with the gold marker and RTRT system, a planning target volume margin should be used to account for registration uncertainty.

[1]  J M Balter,et al.  A comparison of ventilatory prostate movement in four treatment positions. , 2000, International journal of radiation oncology, biology, physics.

[2]  T W Griffin,et al.  Reduction of radioactive seed embolization to the lung following prostate brachytherapy. , 1998, International journal of radiation oncology, biology, physics.

[3]  J Pouliot,et al.  Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. , 1997, International journal of radiation oncology, biology, physics.

[4]  K. Langen,et al.  Organ motion and its management. , 2001, International journal of radiation oncology, biology, physics.

[5]  Shinichi Shimizu,et al.  Real-time tumour-tracking radiotherapy , 1999, The Lancet.

[6]  B W Corn,et al.  Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer. , 1999, International journal of radiation oncology, biology, physics.

[7]  J. Crook,et al.  Prostate motion during standard radiotherapy as assessed by fiducial markers. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  K Lam,et al.  Measurement of prostate movement over the course of routine radiotherapy using implanted markers. , 1995, International journal of radiation oncology, biology, physics.

[9]  M van Herk,et al.  Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. , 1995, International journal of radiation oncology, biology, physics.

[10]  M. V. van Herk,et al.  Physical aspects of a real-time tumor-tracking system for gated radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[11]  S Nag,et al.  Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate. , 1997, International journal of radiation oncology, biology, physics.

[12]  H. Shirato,et al.  Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. , 2000, International journal of radiation oncology, biology, physics.

[13]  G J Kutcher,et al.  Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. , 1997, International journal of radiation oncology, biology, physics.

[14]  W. Butler,et al.  Seed fixity in the prostate/periprostatic region following brachytherapy. , 2000, International journal of radiation oncology, biology, physics.

[15]  C. Pelizzari,et al.  Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. , 1995, International journal of radiation oncology, biology, physics.

[16]  M van Herk,et al.  Comparison of prostate cancer treatment in two institutions: a quality control study. , 1999, International journal of radiation oncology, biology, physics.

[17]  M van Herk,et al.  Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  H Shirato,et al.  Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. , 2000, International journal of radiation oncology, biology, physics.

[19]  M van Herk,et al.  Definition of the prostate in CT and MRI: a multi-observer study. , 1999, International journal of radiation oncology, biology, physics.